Showing results (231-240 of 270) with videos related to

Sort By:
Pageof 27
Biorxiv : the Preprint Server for Biology|February 24, 2023
Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3AStefan Harjes, Harikrishnan M Kurup, Amanda E Rieffer, et al.
Nature Communications|October 11, 2023
Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3AStefan Harjes, Harikrishnan M Kurup, Amanda E Rieffer, et al.
Viruses|September 23, 2022
Small-Angle X-ray Scattering (SAXS) Measurements of APOBEC3G Provide Structural Basis for Binding of Single-Stranded DNA and ProcessivityFareeda M Barzak, Timothy M Ryan, Nazanin Mohammadzadeh, et al.
Dalton Transactions (Cambridge, England : 2003)|July 17, 2019
New salicylaldoximato-borate ligands resulting from anion hydrolysis and their respective copper and iron complexesSidney S Woodhouse, D Nirosha T De Silva, Geoffrey B Jameson, et al.
The Journal of Biological Chemistry|August 8, 2008
Structure and evolution of a novel dimeric enzyme from a clinically important bacterial pathogenBenjamin R Burgess, Renwick C J Dobson, Michael F Bailey, et al.
Investigative Ophthalmology & Visual Science|April 24, 2009
Transient retinal effects of 5,6-dimethylxanthenone-4-acetic acid (DMXAA, ASA404), an antitumor vascular-disrupting agent in phase I clinical trialsMichael B Jameson, Dianne M Sharp, Jennifer I Sissingh, et al.
JAMA Network Open|February 7, 2022
Ethnic Differences in Cancer Rates Among Adults With Type 2 Diabetes in New Zealand From 1994 to 2018Dahai Yu, Zheng Wang, Yamei Cai, et al.
Journal of Medical Entomology|October 4, 2014
Factors associated with peridomestic Triatoma sanguisuga (Hemiptera: Reduviidae) presence in southeastern LouisianaRobin M Moudy, Sarah Michaels, Samuel B Jameson, et al.
Targeted Oncology|December 1, 2017
Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLCMark J McKeage, Dusan Kotasek, Ben Markman, et al.
Biochemistry|October 22, 2008
Mutating the tight-dimer interface of dihydrodipicolinate synthase disrupts the enzyme quaternary structure: toward a monomeric enzymeF Grant Pearce, Renwick C J Dobson, Anke Weber, et al.
Pageof 27